Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial

被引：0
|
作者：
Sun Sun
Håkan Jonsson
Klas-Göran Salén
Mats Andén
Lars Beckman
Per Fransson
机构：
[1] Umeå University,Department of Epidemiology and Global Health
[2] Karolinska Institutet,Research Group Health Outcomes and Economic Evaluation, Department of Learning, Informatics, Management and Ethics
[3] Shandong University,Center for Cancer Control and Policy Research
[4] Kalmar Hospital,Department of Oncology
[5] Sundsvall Hospital,Department of Oncology
[6] Umeå University,Department of Nursing
[7] Umeå University,Department of Radiation Sciences
来源：
The European Journal of Health Economics | 2023年 / 24卷
关键词：
Cost–utility analysis; Prostate cancer; Within-trial economic evaluation; Radiotherapy; Intermediate-to-high-risk cancer; I19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：237 / 246
页数：9
相关论文
共 11 条
  • [1] Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial
    Sun, Sun
    Jonsson, Hakan
    Salen, Klas-Goran
    Anden, Mats
    Beckman, Lars
    Fransson, Per
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (02): : 237 - 246
  • [2] Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial "HYPO-RT-PC"
    Widmark, A.
    Gunnlaugsson, A.
    Beckman, L.
    Thellenberg-Karlsson, C.
    Hoyer, M.
    Lagerlund, M.
    Fransson, P.
    Kindblom, J.
    Ginman, C.
    Johansson, B.
    Seke, M.
    Bjornlinger, K.
    Kjellen, E.
    Franzen, L.
    Nilsson, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05): : 938 - 939
  • [3] Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
    Widmark, Anders
    Gunnlaugsson, Adalsteinn
    Beckman, Lars
    Thellenberg-Karlsson, Camilla
    Hoyer, Morten
    Lagerlund, Magnus
    Kindblom, Jon
    Ginman, Claes
    Johansson, Bengt
    Bjornlinger, Kirsten
    Seke, Mihajl
    Agrup, Mans
    Fransson, Per
    Tavelin, Bjorn
    Norman, David
    Zackrisson, Bjorn
    Anderson, Harald
    Kjellen, Elisabeth
    Franzen, Lars
    Nilsson, Per
    LANCET, 2019, 394 (10196): : 385 - 395
  • [4] Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, 3 trial
    Fransson, Per
    Nilsson, Per
    Gunnlaugsson, Adalsteinn
    Beckman, Lars
    Tavelin, Bjorn
    Norman, David
    Thellenberg-Karlsson, Camilla
    Hoyer, Morten
    Lagerlund, Magnus
    Kindblom, Jon
    Ginman, Claes
    Johansson, Bengt
    Bjornlinger, Kirsten
    Seke, Mihajl
    Agrup, Mans
    Zackrisson, Bjorn
    Kjellen, Elisabeth
    Franzen, Lars
    Widmark, Anders
    LANCET ONCOLOGY, 2021, 22 (02): : 235 - 245
  • [5] Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 32 - 32
  • [6] Implementation of adaptive radiotherapy in a phase III randomized trial comparing hypo-fractionated treatment with conventional fractionated treatment of intermediate risk prostate cancer
    Pos, F.
    Nijkamp, J.
    Remeijer, P.
    Sonke, J.
    van Herk, M.
    Lebesque, J.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S111 - S112
  • [7] Editorial Comment: Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
    Lott, Felipe
    INTERNATIONAL BRAZ J UROL, 2020, 46 (06): : 1100 - 1101
  • [8] Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar IIUltra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: HYPO-RT-PC randomized trial. 5-year results: Commentary II
    Gregor Goldner
    Strahlentherapie und Onkologie, 2019, 195 (12) : 1119 - 1121
  • [9] Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer (HYPO-RT-PC): Patient-Reported Quality-Of-Life Outcomes of a Randomised, Controlled, Non-Inferiority, Phase 3 Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2021, 206 (04): : 1064 - 1064
  • [10] Osteochondroplasty with or without labral repair is more cost-effective than arthroscopic lavage with or without labral repair for treatment of young adults with femoroacetabular impingement: A cost-utility analysis based on data from a randomized controlled trial
    Yan, Jiajun
    Humphries, Brittany
    Bo, Zhenyan
    Dai, Ling
    Simunovic, Nicole
    Xie, Feng
    Ayeni, Olufemi R.
    JOURNAL OF ISAKOS JOINT DISORDERS & ORTHOPAEDIC SPORTS MEDICINE, 2024, 9 (06)
12